Clene (CLNN) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $3.31, +0.00% vs the prior close of $3.31.
- Volume 134.00K shares, 1.2x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CLNN ends flat (+0.0%) to $3.31, 6 down days in a row. Closed at $3.31, +0.00% vs the prior close of $3.31. Day range $3.20–$3.44, opened at $3.25.
CLNN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — CLNN ends flat (+0.0%) to $3.31, 6 down days in a row
- Closed at $3.31, +0.00% vs the prior close of $3.31. Day range $3.20–$3.44, opened at $3.25.
- Volume was 134.00K shares, 1.2x its 50-day average of 112.26K.
- Price is -19.6% vs its 50-day average ($4.12) and -37.5% vs its 200-day average ($5.29).
- 52-week range $3.20–$13.50; today's close sits at 1% of that range, 75.5% below the 52-week high.
- That makes 6 straight losses.
Oct 14, 2026 — CLNN dips 2.4% to $3.31, a 1-month low, 5 down days in a row
- Closed at $3.31, -2.36% vs the prior close of $3.39. Day range $3.24–$3.40, opened at $3.38.
- Volume was 71.40K shares, 0.6x its 50-day average of 111.75K.
- Price is -20.4% vs its 50-day average ($4.16) and -37.6% vs its 200-day average ($5.31).
- 52-week range $3.24–$13.50; today's close sits at 1% of that range, 75.5% below the 52-week high.
- That makes 5 straight losses.
Oct 13, 2026 — CLNN slides 7.9% to $3.39, 4 down days in a row
- Closed at $3.39, -7.88% vs the prior close of $3.68. Day range $3.36–$3.70, opened at $3.69.
- Volume was 114.70K shares, 1.0x its 50-day average of 110.00K.
- Price is -19.2% vs its 50-day average ($4.20) and -36.3% vs its 200-day average ($5.32).
- 52-week range $3.25–$13.50; today's close sits at 1% of that range, 74.9% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 — CLNN slides 4.7% to $3.68, 3 down days in a row
- Closed at $3.68, -4.66% vs the prior close of $3.86. Day range $3.67–$3.93, opened at $3.93.
- Volume was 73.70K shares, 0.7x its 50-day average of 109.20K.
- Price is -13.0% vs its 50-day average ($4.23) and -31.0% vs its 200-day average ($5.34).
- 52-week range $3.25–$13.50; today's close sits at 4% of that range, 72.7% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — CLNN dips 0.5% to $3.86
- Closed at $3.86, -0.52% vs the prior close of $3.88. Day range $3.80–$3.96, opened at $3.83.
- Volume was 48.10K shares, 0.4x its 50-day average of 108.99K — lighter than usual.
- Price is -9.4% vs its 50-day average ($4.26) and -27.9% vs its 200-day average ($5.35).
- 52-week range $3.25–$13.50; today's close sits at 6% of that range, 71.4% below the 52-week high.
Oct 8, 2026 — CLNN dips 1.0% to $3.88
- Closed at $3.88, -1.02% vs the prior close of $3.92. Day range $3.77–$3.96, opened at $3.94.
- Volume was 82.30K shares, 0.7x its 50-day average of 110.15K.
- Price is -9.4% vs its 50-day average ($4.28) and -27.7% vs its 200-day average ($5.36).
- 52-week range $3.25–$13.50; today's close sits at 6% of that range, 71.3% below the 52-week high.
Oct 7, 2026 — CLNN rises 1.3% to $3.92
- Closed at $3.92, +1.29% vs the prior close of $3.87. Day range $3.71–$4.01, opened at $3.85.
- Volume was 40.50K shares, 0.4x its 50-day average of 111.19K — lighter than usual.
- Price is -8.8% vs its 50-day average ($4.30) and -27.1% vs its 200-day average ($5.38).
- 52-week range $3.25–$13.50; today's close sits at 7% of that range, 71.0% below the 52-week high.
Oct 6, 2026 — CLNN dips 1.0% to $3.87
- Closed at $3.87, -1.02% vs the prior close of $3.91. Day range $3.80–$4.04, opened at $3.92.
- Volume was 45.00K shares, 0.4x its 50-day average of 110.85K — lighter than usual.
- Price is -10.4% vs its 50-day average ($4.32) and -28.2% vs its 200-day average ($5.39).
- 52-week range $3.25–$13.50; today's close sits at 6% of that range, 71.3% below the 52-week high.
Oct 5, 2026 — CLNN slides 4.2% to $3.91 on 2.6x normal volume
- Closed at $3.91, -4.17% vs the prior close of $4.08. Day range $3.80–$4.11, opened at $4.09.
- Volume was 278.20K shares, 2.6x its 50-day average of 106.26K — unusually heavy trading.
- Price is -10.2% vs its 50-day average ($4.35) and -27.6% vs its 200-day average ($5.40).
- 52-week range $3.25–$13.50; today's close sits at 6% of that range, 71.0% below the 52-week high.
Oct 2, 2026 — CLNN rises 1.5% to $4.08
- Closed at $4.08, +1.49% vs the prior close of $4.02. Day range $3.97–$4.17, opened at $4.08.
- Volume was 61.50K shares, 0.6x its 50-day average of 106.74K — lighter than usual.
- Price is -6.9% vs its 50-day average ($4.38) and -24.6% vs its 200-day average ($5.41).
- 52-week range $3.25–$13.50; today's close sits at 8% of that range, 69.8% below the 52-week high.
CLNN latest news & SEC filings
Every SEC filing by or about CLNN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Matlin David J received an award of 434,451 shares at $3.28 (≈$1.42M) on Sep 16, 2026; now holds 912,275
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Etherington Robert Dee received an award of 15,244 shares at $3.28 (≈$50.00K) on Sep 16, 2026; now holds 55,393
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Mosca Alison received an award of 198,171 shares at $3.28 (≈$650.00K) on Sep 16, 2026; now holds 478,671
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 8.01 — Reported other events the company considers important.
Sep 16, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $90.00K (prior year $27.00K) (+233.3% vs Jun 30, 2025)
- Net income: -$13.42M (prior year -$7.42M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$1.08 (prior year -$0.78) (loss widened vs Jun 30, 2025)
Aug 11, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Aug 4, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade CLNN
- Last results release: Aug 14, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Mar 12, 2026, Nov 13, 2025. Based on that rhythm, the next report is likely around Nov 13, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.59% (largest 7.9%).
- Liquidity: about 97.94K shares (≈$324.16K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $3.31 vs a range of $3.20–$13.50 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Chidozie Ugwumba sold 73,296 shares on May 12, 2026.
- Latest filings: 8-K Sep 16, 2026; 8-K Aug 14, 2026; 10-Q Aug 14, 2026.
- Share count: 12.85M shares outstanding (Aug 11, 2026), +28.6% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
CLNN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 3.25 | 3.44 | 3.20 | 3.31 | 134.00K |
| Oct 14, 2026 | 3.38 | 3.40 | 3.24 | 3.31 | 71.40K |
| Oct 13, 2026 | 3.69 | 3.70 | 3.36 | 3.39 | 114.70K |
| Oct 12, 2026 | 3.93 | 3.93 | 3.67 | 3.68 | 73.70K |
| Oct 9, 2026 | 3.83 | 3.96 | 3.80 | 3.86 | 48.10K |
| Oct 8, 2026 | 3.94 | 3.96 | 3.77 | 3.88 | 82.30K |
| Oct 7, 2026 | 3.85 | 4.01 | 3.71 | 3.92 | 40.50K |
| Oct 6, 2026 | 3.92 | 4.04 | 3.80 | 3.87 | 45.00K |
| Oct 5, 2026 | 4.09 | 4.11 | 3.80 | 3.91 | 278.20K |
| Oct 2, 2026 | 4.08 | 4.17 | 3.97 | 4.08 | 61.50K |
| Oct 1, 2026 | 4.10 | 4.15 | 4.00 | 4.02 | 100.00K |
| Sep 30, 2026 | 4.14 | 4.33 | 4.01 | 4.08 | 51.80K |
| Sep 29, 2026 | 4.10 | 4.26 | 4.06 | 4.10 | 70.40K |
| Sep 28, 2026 | 4.24 | 4.37 | 4.01 | 4.06 | 91.70K |
| Sep 25, 2026 | 4.15 | 4.49 | 4.12 | 4.30 | 136.40K |
| Sep 24, 2026 | 4.27 | 4.38 | 4.09 | 4.21 | 47.70K |
| Sep 23, 2026 | 4.36 | 4.44 | 4.15 | 4.29 | 75.20K |
| Sep 22, 2026 | 4.51 | 4.70 | 4.27 | 4.38 | 135.80K |
| Sep 21, 2026 | 4.40 | 4.70 | 4.40 | 4.54 | 108.90K |
| Sep 18, 2026 | 4.16 | 4.44 | 4.05 | 4.35 | 191.40K |
About Clene
Clene (CLNN) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SALT LAKE CITY, UT. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1822791.
CLNN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Arjun Jj Desai | Director | Aug 14, 2026 |
| Robert Dee Etherington | President & CEO | Sep 18, 2026 |
| Jonathon Gay | Director | Aug 14, 2026 |
| Shalom Jacobovitz | Director | Aug 14, 2026 |
| Matthew Kiernan | Director | Aug 14, 2026 |
| David J Matlin | Director | Sep 18, 2026 |
| Vallerie Mclaughlin | Director | Aug 14, 2026 |
| Alison Mosca | Director | Sep 18, 2026 |
| Reed N Wilcox | Director | Aug 14, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Morgan R Brown | Chief Financial Officer | Jun 15, 2026 |
| Robert Dee Etherington | President & CEO | Sep 18, 2026 |
| Mark Mortenson | Chief Science Officer | Jun 15, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 12, 2026 | Chidozie Ugwumba | Sale | 73,296 | $6.20 |
| May 11, 2026 | Chidozie Ugwumba | Sale | 22,177 | $6.75 |
| May 4, 2026 | Chidozie Ugwumba | Sale | 72,884 | $6.80 |
| May 1, 2026 | Chidozie Ugwumba | Sale | 5,795 | $6.01 |
| Apr 30, 2026 | Chidozie Ugwumba | Sale | 5,736 | $6.08 |
| Apr 29, 2026 | Chidozie Ugwumba | Sale | 12,170 | $5.63 |
| Apr 28, 2026 | Chidozie Ugwumba | Sale | 1,591 | $5.90 |
| Apr 21, 2026 | Chidozie Ugwumba | Sale | 61,345 | $6.14 |
| Apr 20, 2026 | Chidozie Ugwumba | Sale | 4,318 | $6.12 |
| Apr 17, 2026 | Chidozie Ugwumba | Sale | 25,040 | $6.43 |
| Apr 16, 2026 | Chidozie Ugwumba | Sale | 7,748 | $6.40 |
| Apr 15, 2026 | Chidozie Ugwumba | Sale | 6,374 | $6.48 |
| Apr 2, 2026 | Chidozie Ugwumba | Sale | 24,925 | $4.81 |
| Apr 1, 2026 | Chidozie Ugwumba | Sale | 4,278 | $4.97 |
| Mar 31, 2026 | Chidozie Ugwumba | Sale | 67,991 | $4.88 |
CLNN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $200.00K | $-26.17M | -2.65 | $-18.55M |
| Dec 31, 2024 | $342.00K | $-39.40M | -5.67 | $-21.33M |
| Dec 31, 2023 | $654.00K | $-49.50M | -9.43 | $-30.17M |
| Dec 31, 2022 | $473.00K | $-29.92M | -0.46 | $-39.01M |
| Dec 31, 2021 | $723.00K | $-9.74M | -0.16 | $-34.62M |
Latest balance sheet: total assets $23.04M, total liabilities $47.82M, cash $9.67M (as of Jun 30, 2026).
CLNN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 14, 2026 | 8-K Item 2.02 (results) | $4.14 |
| May 14, 2026 | 8-K Item 2.02 (results) | $7.05 |
| Mar 12, 2026 | 8-K Item 2.02 (results) | $5.92 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $7.30 |
| Oct 14, 2025 | 8-K Item 2.02 (results) | $8.59 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $3.60 |
| May 7, 2025 | 8-K Item 2.02 (results) | $2.55 |
| Mar 24, 2025 | 8-K Item 2.02 (results) | $3.92 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $4.82 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 8, 2024 | 8-K Item 2.02 (results) | — |
| Mar 13, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on CLNN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.